螺旋扩张器用于胰胆疾病:美国首经验
回顾性单中心研究分析2025年6月至2026年1月使用Tornus ES螺旋扩张器辅助治疗性EUS和ERCP扩张通道的21例操作(20例患者),技术成功率为95%(20/21),不良事件发生在40%(8/20)患者中,但无直接归因于器械故障。结论认为该器械是胰胆疾病治疗中的有效补救工具。
要点
- Tornus ES螺旋扩张器在治疗性EUS和ERCP中技术成功率达95%。
- 不良事件发生率40%,但均未直接归因于器械故障。
- 该器械可作为胰胆疾病通道扩张的补救工具。
核心结论
- Tornus ES螺旋扩张器在治疗性EUS和ERCP中用于胰胆疾病通道扩张是有效且安全的补救工具。
研究设计与样本
- 回顾性单中心研究,分析2025年6月至2026年1月使用Tornus ES进行通道扩张的治疗性EUS和ERCP操作,共21例操作(20例患者)。
主要发现
- 技术成功率为95%(20/21例操作),定义为成功在扩张通道上放置支架。
- 干预方式包括ERCP(38%)和治疗性EUS(62%)。
- 不良事件发生于40%(8/20)的患者,但无事件直接归因于器械故障。
临床怎么用
- 在治疗性EUS和ERCP中,当常规扩张困难时,可考虑使用Tornus ES螺旋扩张器作为补救手段。
局限性
- 回顾性单中心设计,样本量小(20例患者),结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Creating adequate tracts for device passage remains a challenge in ERCP and therapeutic EUS. We evaluated the technical success and safety of the Tornus ES (Asahi Intecc, Aichi, Japan) screw dilator for tract dilation during therapeutic EUS and ERCP. METHODS: This retrospective, single-center study analyzed dilation of tracts during therapeutic EUS and ERCP using the Tornus ES from June 2025 to January 2026. Technical success was defined as successful stent placement across the dilated tract. RESULTS: Twenty-one procedures (20 patients) were performed for biliary strictures, pancreatic duct obstructions, and bile leaks. Technical success was 95% (20 of 21 procedures). Interventions included ERCP (38%) and therapeutic EUS (62%). Adverse events occurred in 40% (8 of 20) of patients-none directly attributed to device failure. CONCLUSIONS: This first U.S. experience demonstrates that the Tornus ES screw dilator is an effective salvage tool during therapeutic EUS and ERCP for pancreaticobiliary disease.
引用
- Gainey CS, Manudhane A, Baron TH, et al. Use of a screw dilator for pancreaticobiliary disease. Gastrointest Endosc. 2026. PMID: 41786150. doi:10.1016/j.gie.2026.02.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。